Dr. Joseph Kozikowski will present a series of lectures to faculty, industry executives, and government officials at CBNU, Korea’s leading university for bio-health industry development.
NATICK, MA – November 18, 2012 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph Kozikowski, M.D. will lead an international academic symposium at Chungbuk National University in Cheongju, Korea on industrial development of pharmaceutical, biotechnology, and medtech industries.
As an authority on the development and commercialization of advanced medical technology, Dr. Kozikowski will share his perspectives in a wide-ranging series of lectures entitled as follows:
- “Value Creation in the Medical Products Industry: Markets, Risks, and Returns”
- “Medical Product Development: Realizing Product Vision”
- “Global Market Access of Medical Products: Pathways to Commercialization”
- “Corporate Development in the Medical Products Industry: Partnering, Restructuring, and Dealmaking”
The symposium will include Korean and international faculty, students, industry executives, and government officials, and will be held on November 28, 2012 at The College of Pharmacy, Chungbuk National University, Cheongju, Korea. Further details are available in English and Korean printed and online announcements, available through the Office of the Dean at The College of Pharmacy, Chungbuk National University.
Following the presentation, Dr. Kozikowski will be available for academic discussions, industry meetings, and media briefings to discuss the topics in greater depth. A reception will follow in Cheongju.
Quotes & Commentary:
“It is an honor to have been invited to lead this symposium, and I thank Dean Ki-Wan Oh for his efforts in ensuring what will be an outstanding international event,” said clinivation Founder and CEO Joseph Kozikowski, M.D.
About Chungbuk National University:
Chungbuk National University (CBNU) is one of Korea’s leading educational and research institutions. A regional research center for Bio Health Industry Development, CBNU’s Biomedical Systems Development Center has been awarded funding by Korea’s Ministry of Health and Welfare.
The Health, Medicine, and Life Science Program was the first program to develop a systematic, interdisciplinary curriculum connecting and combining basic sciences and applied technologies.
As part of the Osong BioTechnopolis- Korea’s leading industry cluster for health, medicine, and life science related industries, research institutes, and government offices- CBNU will play a major role in Korea’s growing life sciences industry.
